Bladder Cancer Clinical Trials in Xiamen, Fujian
2 recruitingXiamen, Fujian, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital25 enrolled12 locationsNCT07296705
Recruiting
Phase 1Phase 2
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
Bladder CancerNon Muscle Invasive
Zhuhai Beihai Biotech Co., Ltd48 enrolled6 locationsNCT06732531